Fund Holdings — Exome Asset Management LLC

Total Portfolio Value:
$112.32M
Total Bought:
$56.89M
Total Sold:
$65.07M
Net Transaction:
-$8.19M
Notable People:
Alex R Forschner
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)9,7009,7000$7.55M$8.78M7.82%+$1.24M
Sarepta Therapeutics, Inc.(SRPT)032,900+32,900$0$5.20M4.63%+$5.20M
BeOne Medicines AGADR(ONC)36,80033,200-3,600$5.76M$4.74M4.22%-$1.02M
TG Therapeutics, Inc.(TGTX)230,300251,600+21,300$3.50M$4.48M3.99%+$973.1K
The Cigna Group(CI)15,30012,200-3,100$5.56M$4.03M3.59%-$1.52M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)87,84684,790-3,056$3.45M$3.84M3.42%+$389.7K
Insmed Incorporated(INSM)71,70056,800-14,900$1.95M$3.81M3.39%+$1.86M
Amgen Inc.(AMGN)011,800+11,800$0$3.69M3.28%+$3.69M
Travere Therapeutics, Inc.(TVTX)362,487443,379+80,892$2.79M$3.64M3.24%+$849.8K
Madrigal Pharmaceuticals, Inc.(MDGL)7,90010,800+2,900$2.11M$3.03M2.69%+$916.1K
Avadel Pharmaceuticals Plc0209,092+209,092$0$2.94M2.62%+$2.94M
DexCom, Inc.(DXCM)24,82825,928+1,100$3.44M$2.94M2.62%-$503.9K
Autolus Therapeutics plcADS(AUTL)0839,472+839,472$0$2.92M2.60%+$2.92M
Intuitive Surgical, Inc.(ISRG)6,3586,3580$2.54M$2.83M2.52%+$290.9K
Dr. Reddy's Laboratories LimitedADR(RDY)86,00036,300-49,700$6.31M$2.77M2.46%-$3.54M
Disc Medicine, Inc.(IRON)061,000+61,000$0$2.75M2.45%+$2.75M
Ascendis Pharma A/SADR(ASND)020,000+20,000$0$2.73M2.43%+$2.73M
Kura Oncology, Inc.(KURA)0131,742+131,742$0$2.71M2.42%+$2.71M
Merus N V045,100+45,100$0$2.67M2.38%+$2.67M
Masimo Corp019,800+19,800$0$2.49M2.22%+$2.49M
Centessa Pharmaceuticals PlcADS274,900274,9000$3.11M$2.48M2.21%-$624.0K
Wave Life Sciences, Inc.SHS(WVE)0488,135+488,135$0$2.44M2.17%+$2.44M
Guardant Health, Inc.(GH)79,00079,0000$1.63M$2.28M2.03%+$651.8K
Cabaletta Bio, Inc.(CABA)0300,200+300,200$0$2.25M2.00%+$2.25M
Arvinas, Inc.(ARVN)082,400+82,400$0$2.19M1.95%+$2.19M
Natera, Inc.(NTRA)18,65018,6500$1.71M$2.02M1.80%+$313.9K
Biohaven Ltd.(BHVN)057,800+57,800$0$2.01M1.79%+$2.01M
BridgeBio Pharma, Inc.(BBIO)48,80778,907+30,100$1.51M$2.00M1.78%+$489.6K
Fulcrum Therapeutics, Inc.(FULC)0302,700+302,700$0$1.88M1.67%+$1.88M
Apellis Pharmaceuticals Inc
COM
046,900+46,900$0$1.80M1.60%+$1.80M
Alphatec Holdings, Inc.(ATEC)0162,100+162,100$0$1.69M1.51%+$1.69M
AbCellera Biologics Inc.(ABCL)0514,900+514,900$0$1.52M1.36%+$1.52M
Zai Lab LimitedADR(ZLAB)65,30086,700+21,400$1.05M$1.50M1.34%+$456.4K
Pliant Therapeutics, Inc.(PLRX)0124,000+124,000$0$1.33M1.19%+$1.33M
Rezolute, Inc.(RZLT)0282,400+282,400$0$1.21M1.08%+$1.21M
Alvotech(ALVO)099,000+99,000$0$1.20M1.07%+$1.20M
Gossamer Bio, Inc.(GOSS)01,127,699+1,127,699$0$1.02M0.90%+$1.02M
Elevation Oncology Inc369,322369,3220$1.89M$997.2K0.89%-$897.5K
Establishment Labs Holdings Inc.(ESTA)021,700+21,700$0$986.0K0.88%+$986.0K
Syros Pharmaceuticals Inc0159,175+159,175$0$821.3K0.73%+$821.3K
Quanterix Corporation(QTRX)59,65059,6500$1.41M$788.0K0.70%-$617.4K
Q32 Bio Inc.(QTTB)65,02143,865-21,156$1.11M$787.4K0.70%-$320.6K
Yarrow Bioscience Inc(YARW)415,434353,434-62,000$1.28M$696.3K0.62%-$579.1K
PMV Pharmaceuticals, Inc.(PMVP)0358,400+358,400$0$580.6K0.52%+$580.6K
Aprea Therapeutics, Inc.(APRE)0137,174+137,174$0$558.3K0.50%+$558.3K
Tectonic Therapeutic, Inc.(TECX)032,389+32,389$0$533.4K0.47%+$533.4K
Adagene IncADS155,383150,876-4,507$435.1K$461.8K0.41%+$26.8K
NovaBridge BiosciencesADS(NBP)325,762271,400-54,362$605.9K$453.2K0.40%-$152.7K
Procaps Group SaSHS0126,901+126,901$0$321.1K0.29%+$321.1K
Hillevax Inc018,000+18,000$0$260.3K0.23%+$260.3K
Sagimet Biosciences Inc.COM SER A(SGMT)60,90050,700-10,200$330.1K$173.4K0.15%-$156.7K
Pacific Biosciences of California, Inc.(PACB)75,30075,3000$282.4K$103.2K0.09%-$179.2K
Aerovate Therapeutics Inc98,4850-98,485$2.91M$0—-$2.91M
Agios Pharmaceuticals, Inc.(AGIO)59,9020-59,902$1.75M$0—-$1.75M
Alpine Immune Sciences Inc117,0000-117,000$4.64M$0—-$4.64M
Arrowhead Pharmaceuticals, Inc.(ARWR)55,7000-55,700$1.59M$0—-$1.59M
Avidity Biosciences Inc135,1690-135,169$3.45M$0—-$3.45M
Avrobio Inc61,1350-61,135$78.3K$0—-$78.3K
Biogen Inc.(BIIB)8,2000-8,200$1.77M$0—-$1.77M
Celldex Therapeutics, Inc.(CLDX)71,1000-71,100$2.98M$0—-$2.98M
Cytokinetics, Incorporated(CYTK)26,0080-26,008$1.82M$0—-$1.82M
Enliven Therapeutics Inc57,6350-57,635$1.01M$0—-$1.01M
Endeavour Silver Corp.(EXK)26,7000-26,700$1.84M$0—-$1.84M
Geron Corporation(GERN)886,8000-886,800$2.93M$0—-$2.93M
Inari Med Inc30,1000-30,100$1.44M$0—-$1.44M
Inozyme Pharma Inc273,4130-273,413$2.09M$0—-$2.09M
Intra-Cellular Therapies Inc20,3000-20,300$1.40M$0—-$1.40M
Krystal Biotech, Inc.(KRYS)14,7000-14,700$2.62M$0—-$2.62M
Marinus Pharmaceuticals Inc163,1000-163,100$1.47M$0—-$1.47M
Morphosys AgADS154,8000-154,800$2.81M$0—-$2.81M
Ocular Therapeutix, Inc.(OCUL)193,6000-193,600$1.76M$0—-$1.76M
Olema Pharmaceuticals, Inc.(OLMA)143,4000-143,400$1.62M$0—-$1.62M
Penumbra, Inc.(PEN)7,3530-7,353$1.64M$0—-$1.64M
REGENXBIO Inc.(RGNX)84,4700-84,470$1.78M$0—-$1.78M
Regulus Therapeutics Inc402,5040-402,504$1.16M$0—-$1.16M
Rhythm Pharmaceuticals, Inc.(RYTM)45,6030-45,603$1.98M$0—-$1.98M
Shockwave Med Inc4,0000-4,000$1.30M$0—-$1.30M
Tarsus Pharmaceuticals, Inc.(TARS)66,3000-66,300$2.41M$0—-$2.41M
Terns Pharmaceuticals Inc227,8210-227,821$1.49M$0—-$1.49M
Ultragenyx Pharmaceutical Inc.(RARE)17,8000-17,800$831.1K$0—-$831.1K
Ventyx Biosciences Inc163,9220-163,922$901.6K$0—-$901.6K
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q2 2024 | TickerTrail